MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 146 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,548,223 | -50.3% | 51,686 | -21.4% | 0.04% | -48.7% |
| Q2 2023 | $15,190,791 | -8.7% | 65,761 | -4.2% | 0.08% | -15.6% |
| Q1 2023 | $16,634,541 | -5.1% | 68,664 | +13.7% | 0.09% | -10.9% |
| Q4 2022 | $17,533,132 | +979.6% | 60,407 | +141.7% | 0.10% | +818.2% |
| Q3 2022 | $1,624,000 | +237.6% | 24,989 | +271.6% | 0.01% | +266.7% |
| Q2 2022 | $481,000 | +46.2% | 6,725 | +100.8% | 0.00% | +50.0% |
| Q1 2022 | $329,000 | -12.7% | 3,349 | -24.7% | 0.00% | 0.0% |
| Q4 2021 | $377,000 | +83.9% | 4,445 | +72.7% | 0.00% | +100.0% |
| Q3 2021 | $205,000 | -72.7% | 2,574 | -61.3% | 0.00% | -80.0% |
| Q4 2018 | $750,000 | -58.5% | 6,650 | -21.3% | 0.01% | -50.0% |
| Q3 2018 | $1,809,000 | – | 8,450 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
| University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
| Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
| TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
| Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
| Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
| Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
| Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
| MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
| Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |